| Bioactivity | GLEWVAEIR-(Arg-13C6,15N4) (TFA) is the peptide containing 13C- and 15N-labeled Arg. |
| Invitro | 氢、碳和其他元素的稳定重同位素已被纳入药物分子中，主要作为药物开发过程中定量的示踪剂。氘化引起了人们的关注，因为它可能影响药物的药代动力学和代谢谱[1]。 0 --> GLEWVAEIR-(Arg-13C6,15N4) (TFA) 相关抗体: |
| Name | GLEWVAEIR-(Arg-13C6,15N4) (TFA) |
| Sequence | Gly-Leu-Glu-Trp-Val-Ala-Glu-Ile-{Arg(13C6,15N4)} (TFA salt) |
| Shortening | GLEWVAEIR-{Arg(13C6,15N4)} (TFA salt) |
| Formula | C4313C6H77N915N4O14.xC2HF3O2 |
| Molar Mass | 1082.14 (free acid) |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
GLEWVAEIR-(Arg-13C6,15N4) (TFA)
CAS: F: C4313C6H77N915N4O14.xC2HF3O2 W: 1082.14 (free acid)
GLEWVAEIR-(Arg-13C6,15N4) (TFA) is the peptide containing 13C- and 15N-labeled Arg.
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.